Healix Infusion Therapy - 503B Compounding Pharmacy Services Unit's Unit Acquisition

Healix Infusion Therapy - 503B Compounding Pharmacy Services Unit raised a round of funding on August 24, 2015. Investors include QuVa Pharma.

Healix Infusion Therapy is driven by its mission of helping healthcare facilities and medical providers offer excellence in patient care. With corporate headquarters in Sugar Land, Texas, Healix is th…

Articles about Healix Infusion Therapy - 503B Compounding Pharmacy Services Unit's Unit Acquisition: